CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

Hung-Yao Lin, Tai-Chung Tseng

Clin Mol Hepatol. 2022;28(2):181-182. Published online 2022 February 21 DOI: https://doi.org/10.3350/cmh.2022.0028

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

Hung-Yao Lin, Tai-Chung Tseng

Clinical and Molecular Hepatology. 2022;28(2):181-182

Link1

Link2 Link3

PGI3 Comparative Safety of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in Chronic Hepatitis B Patients

N.Y. Yu, K.C. Chang

Value in Health. 2020;23:S533

Link1 Link2

O-043: Safety and efficacy at 1 year after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic HBV patients with risk factors for TDF use

Journal of Viral Hepatitis. 2018;25:27-27

Link1 Link2

Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B

Sara Jeong, Hyun Phil Shin, Ha Il Kim

Intervirology. 2021;65(2):94-103

Link1 Link2

Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B

Tomoya Sano, Takumi Kawaguchi, Tatsuya Ide, Keisuke Amano, Reiichiro Kuwahara, Teruko Arinaga-Hino, Takuji Torimura

Life. 2021;11(3):263

Link1

Tenofovir Alafenamide: A Review in Chronic Hepatitis B

Lesley J. Scott, Henry L. Y. Chan

Drugs. 2017;77(9):1017-1028

Link1 Link2

Link3

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study

Pei-Yuan Su, Wei-Wen Su, Yu-Chun Hsu, Siou-Ping Huang, Hsu-Heng Yen

PeerJ. 2021;9:e12527

Link1

Link2 Link3 Link4

Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide

Tse‐Ling Fong, Brian T. Lee, Andy Tien, Mimi Chang, Carolina Lim, Aiden Ahn, Ho S. Bae

Journal of Viral Hepatitis. 2019;26(5):561-567

Link1 Link2 Link3 Link4

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy

Eiichi Ogawa, Norihiro Furusyo, Mindie H Nguyen

Drug Design, Development and Therapy. 2017;Volume 11:3197-3204

Link1 Link2

Bone and renal safety profile at 72 weeks after switching to tenofovir alafenamide in chronic hepatitis B patients

Brian T Lee, Mimi Chang, Carolina Lim, Ho S Bae, Tse‐Ling Fong

JGH Open. 2020;5(2):258-263

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.